Dr. Robert Thomas Ryan , MD
Urology • Seguin, TX
1339 E Court Street, Suite 220
Seguin, TX 781555141
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 17, 2006; this date does not establish years in practice.
-
Published CMS data list 3,032 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 693 service units.
- 99213 — Established patient outpatient office visit: 546 service units.
- 81000 — Manual urinalysis test with examination using microscope, non-automated: 518 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 20 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,054 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 728 prescription fills, including refills.
- Myrbetriq (Mirabegron) — 260 prescription fills, including refills.
- Finasteride — 214 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 34 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 60% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 87,254 in 2020 to 3,032 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1339 E Court Street
Suite 220
Seguin, TX 781555141
CMS Doctors and Clinicians lists 1 group name: Guadalupe Regional Medical Group. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Texas Medical School At San Antonio
1998
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
781 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $232,023 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $173,617 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
6,245 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$815,769 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $794.67 across 18 records.
By nature of payment
- Food and Beverage: $709.62 across 17 records.
- Education: $85.05 across 1 record.
Reporting-company totals (3 largest of 8)
- INTUITIVE SURGICAL, INC.: $390.68 across 1 record.
- Sumitomo Pharma America, Inc.: $175.73 across 8 records.
- Astellas Pharma US Inc: $104.73 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
28 years (graduated 1998)
CMS Doctors and Clinicians data list 1998 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ryan has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ryan as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Seguin and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 60% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Too few clinicians listed under Urology in Seguin have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Too few clinicians listed under Urology in Seguin have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Too few clinicians listed under Urology in Seguin have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Too few clinicians listed under Urology in Seguin have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
Too few clinicians listed under Urology in Seguin have Medicare Part D data for 2024 to compare.
3 active clinicians are listed under Urology with a practice address in Seguin, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 97% from 87,254 in 2020 to 3,032 in 2024.
- 2020: 87,254
- 2021: 85,863
- 2022: 95,344
- 2023: 35,082
- 2024: 3,032
-
Medicare-allowed amount
Medicare-allowed amount decreased 14% from $268,736 in 2020 to $232,023 in 2024.
- 2020: $268,736
- 2021: $256,686
- 2022: $241,556
- 2023: $220,808
- 2024: $232,023
-
Paid by Medicare
Paid by Medicare decreased 13% from $200,597 in 2020 to $173,617 in 2024.
- 2020: $200,597
- 2021: $192,462
- 2022: $181,809
- 2023: $163,848
- 2024: $173,617
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 21% from 2,527 in 2020 to 3,054 in 2024.
- 2020: 2,527
- 2021: 2,204
- 2022: 2,205
- 2023: 2,624
- 2024: 3,054
-
30-day fills
30-day fills increased 22% from 5,124 in 2020 to 6,245 in 2024.
- 2020: 5,124
- 2021: 4,780
- 2022: 4,757
- 2023: 5,368
- 2024: 6,245
-
Part D drug cost
Part D drug cost increased 163% from $309,601 in 2020 to $815,769 in 2024.
- 2020: $309,601
- 2021: $303,842
- 2022: $438,647
- 2023: $638,421
- 2024: $815,769
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $159.82 in 2021 to $794.67 in 2025.
- 2021: $159.82
- 2022: $387.17
- 2023: $501.89
- 2024: $442.12
- 2025: $794.67
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 18 records totaling $794.67.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. |
Food and Beverage
In-kind items and services
|
Da Vinci Surgical System | General | $390.68 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $85.05 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $28.12 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $27.78 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.32 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.09 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $21.28 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $20.25 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $20.22 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $20.03 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $19.68 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $19.60 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $19.54 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $17.08 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $16.10 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $15.31 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
— | General | $13.91 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $11.63 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
693 | 421 | $303.00 | $119.00 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
546 | 407 | $214.00 | $84.22 |
|
81000
Manual urinalysis test with examination using microscope, non-automated
|
518 | 311 | $9.99 | $3.94 |
|
81002
Urinalysis, manual test
|
251 | 195 | $9.00 | $3.40 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
217 | 26 | $1261.00 | $178.11 |
|
96372
Injection of drug or substance under skin or into muscle
|
204 | 18 | $60.00 | $13.29 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
184 | 143 | $50.00 | $10.27 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
113 | 113 | $395.00 | $156.31 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
74 | 65 | $562.39 | $216.49 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
52 | 26 | $80.00 | $32.31 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
39 | 37 | $25.00 | $15.38 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
21 | 19 | $569.00 | $69.58 |
|
76872
Ultrasound scan of pelvic region through rectum
|
19 | 18 | $229.00 | $32.95 |
|
55700
Biopsy of prostate gland
|
18 | 18 | $572.00 | $118.48 |
|
52601
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope
|
16 | 16 | $1715.00 | $677.45 |
|
76942
Ultrasonic guidance for needle placement
|
16 | 15 | $161.31 | $27.85 |
|
76872
Ultrasound scan of pelvic region through rectum
|
14 | 12 | $331.00 | $126.62 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
13 | 12 | $55.00 | $21.23 |
|
55700
Biopsy of prostate gland
|
12 | 12 | $572.00 | $222.16 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
12 | 12 | $265.00 | $103.71 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 728 | 56,310 | $13,759.48 | 226 |
| Myrbetriq | Mirabegron | 260 | 14,040 | $207,282.28 | 73 |
| Finasteride | Finasteride | 214 | 18,259 | $3,254.96 | 72 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 186 | 13,324 | $4,772.94 | 60 |
| Gemtesa | Vibegron | 167 | 7,858 | $120,938.11 | 41 |
| Cefuroxime | Cefuroxime Axetil | 161 | 1,419 | $2,432.73 | 128 |
| Solifenacin Succinate | Solifenacin Succinate | 147 | 9,810 | $3,925.69 | 48 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 143 | 1,075 | $555.02 | 108 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 131 | 6,136 | $6,429.48 | 67 |
| Testosterone Cypionate | Testosterone Cypionate | 121 | 6,420 | $5,527.23 | 35 |
| Anastrozole | Anastrozole | 91 | 5,831 | $234.10 | 34 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 73 | 5,610 | $1,796.73 | 26 |
| Bicalutamide | Bicalutamide | 60 | 4,237 | $2,184.49 | 22 |
| Silodosin | Silodosin | 60 | 3,298 | $4,868.71 | 16 |
| Levofloxacin | Levofloxacin | 59 | 502 | $253.58 | 37 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 52 | 1,617 | $458.37 | 26 |
| Cephalexin | Cephalexin | 39 | 2,508 | $362.80 | 18 |
| Orgovyx | Relugolix | 38 | 1,140 | $101,171.42 | — |
| Mirabegron Er | Mirabegron | 38 | 3,120 | $29,575.85 | 22 |
| Estradiol | Estradiol | 37 | 2,485 | $2,538.96 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 259 | $245.34 | 18 |
| Dutasteride | Dutasteride | 25 | 2,250 | $781.52 | — |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 24 | 98 | $133.99 | 20 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 21 | 1,430 | $3,214.45 | — |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | 1,350 | $257.29 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20041115000213
TX
5799749313
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Guadalupe Regional Medical Group
105 Medical, Seguin, TX 781555392
Phone: 8304017558
Career & Practice History
NPI enumerated October 17, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Seguin
Healthcare providers in SeguinMailing Address
1339 E Court Street, Suite 220
Seguin, TX 781555141
Phone: 8303798491